Literature DB >> 17195872

The digestive system and nutritional considerations for individuals with Rett syndrome.

Meir Lotan1, Lilit Zysman.   

Abstract

Rett syndrome (RS) is a neurodevelopmental syndrome of genetic origin that mainly affects females. Individuals diagnosed with RS exhibit a variety of functional difficulties that impair their quality of life. One of the affected systems is the digestive system, where 74% of persons with RS have abnormal functioning. The affected digestive system causes this population to present an array of problems, such as gastroesophageal reflux (GER), constipation, and malnutrition, leading to failure to thrive (FTT), which resolves in reduced functional ability. Due to the severe effects of the dysfunctional digestive system of individuals with RS, this article will describe the problems common to this population, as well as propose some clinical suggestions for intervention.

Entities:  

Mesh:

Year:  2006        PMID: 17195872      PMCID: PMC5917384          DOI: 10.1100/tsw.2006.264

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  3 in total

Review 1.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

2.  Correlation Between Dysphagia and Malocclusion in Rett Syndrome: A preliminary study.

Authors:  Serena Cocca; Massimo Viviano; Michele Loglisci; Stefano Parrini; Giovanni Monciatti; Ilaria I Paganelli; Walter Livi; Chiara Mezzedimi
Journal:  Sultan Qaboos Univ Med J       Date:  2019-03-28

3.  Exploring the characteristics and most bothersome symptoms in MECP2 duplication syndrome to pave the path toward developing parent-oriented outcome measures.

Authors:  Muharrem Ak; Bernhard Suter; Zekeriya Akturk; Holly Harris; Kristina Bowyer; Laurence Mignon; Sasidhar Pasupuleti; Daniel G Glaze; Davut Pehlivan
Journal:  Mol Genet Genomic Med       Date:  2022-06-15       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.